FDA News Release (Food and Drug Administration)
FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose
Naloxone in nasal spray form provides important new alternative for family members, first responders.
Drug overdose deaths, driven largely by prescription drug overdoses, are now the leading cause of injury death in the United States – surpassing motor vehicle crashes. READ MORE